Close

More on DNLI

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+12.5% Growth)
- Ratings (8.6 Score)

Upcoming Events

- Earnings (5/2/24)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Denali Therapeutics (NQ:DNLI)
Delayed: 17.34 -0.5 (2.8%)
Prev. Close $17.84  
Open$17.59 
52 Wk High$ 
52 Wk Low$ 
Day High$17.60 
Day Low$17.15 
P/E N/A  
EPS$ 
Volume1,080,929 

Friends, Peers and Foes (?): OMGA, FHTX, MCRB, MRNA, SANA (more...)

Apr 15, 2024 04:32 PM Form 144 Denali Therapeutics Inc. Filed by: SATO VICKI L
Apr 9, 2024 09:59 AM Denali Therapeutics Inc. (DNLI) PT Lowered to $32 at UBS
Apr 8, 2024 08:00 AM Flagship Appoints Amy O'Shea as CEO-Partner and Chief Executive Officer of Invaio Sciences
Apr 2, 2024 06:08 PM Form 4 Denali Therapeutics Inc. For: Apr 01 Filed by: Krognes Steve E.
Apr 1, 2024 04:36 PM Form 144 Denali Therapeutics Inc. Filed by: Krognes Steve E.
Mar 29, 2024 05:59 PM Form 4 Denali Therapeutics Inc. For: Mar 29 Filed by: Watts Ryan J.
Mar 22, 2024 04:04 PM Denali Therapeutics (DNLI) Announces 29.29M Share Offering by Selling Stockholders
Mar 22, 2024 04:02 PM Form S-3ASR Denali Therapeutics Inc.
Mar 19, 2024 04:33 PM Form 4 Denali Therapeutics Inc. For: Mar 15 Filed by: SATO VICKI L
Mar 19, 2024 08:30 AM Flagship Pioneering Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024
View All Articles

Entities mentioned with dnli

View All Entities